A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenario

Table 1 Sequences of primers used for quantitative RT-PCR

Gene	Forward primer (5′–3′)	Reverse primer (5′–3′)	Product length (bp)
B2m	CCTGCAGAGTTAAGCATGCCAG	TGCTTGATCACATGTCTCGATCC	72
Ccl2	CCCTCAACGGAAGAACCAAA	CACATCAGGTACGATCCAGGC	72
Ccl3	AACATCATGAAGGTCTCCAC	CCAAGACTCTCAGGCATTCA	294
Ccl4	GCCCTCTCTCTCCTCTTGCT	GTCTGCCTCTTTTGGTCAGG	196
Ccl5	GGTACCATGAAGATCTCTGCA	AAACCCTCTATCCTAGCTCAT	294
Ccl20	TTTTGGGATGGAATTGGACAC	TGCAGGTGAAGCCTTCAACC	69
Cxcr4	TTCTCATCCTGGCCTTCATC	CTTTTCAGCCAGCAGTTTCC	92
Cxcr7	GCCGTACCATTTTGTGGTTC	TGCAACGCTGTAAAGAGCAC	96
Cxcl1	CTTGGTTCAGAAAATTGTCCAAAA	ACGGTGCCATCAGAGCAGTCT	84
Cxcl9	TGGAGCAGTGTGGAGTTCGA	CCTCGGCTGGTGCTGATG	73
Cxcl10	GCCGTCATTTTCTGCCTCAT	GCTTCCCTATGGCCCTCATT	127
Cxcl11	CAAAATGGCAGAGATCGAGAAA	TGAGCCTTCATAGTAACAATCACTTCA	87
Cxcl12	GAAGTGGAGCCATAGTAATGCC	TCCAAGTGGAAAAATACACCG	133
Cxcl13	CAACTGTTGTCGGTCTAAACATCAT	GGTCCAGATCACAACTTCAGTTTTG	89
Gal-1 (Galectina-1)	TGAACCTGGGAAAAGACAGC	TCAGCCTGGTCAAAGGTGAT	190
Il2	CCTGAGCAGGATGGAGAATTACA	CTTTCAATTCTGTGGCCTGCTTGGG	92
Il4	ACAGGAGAAGGGACGCCAT	GAAGCCCTACAGACGAGCTCA	95
Il6	GTTCTCTGGGAAATCGTGGAAA	AAGTGCATCATCGTTGTTCATACA	78
Il10	CATTTGAATTCCCTGGGTGAGA	TGCTCCACTGCCTTGCTCTT	101
Il12	ATCACACGGGACCAAACCA	CAGGCAACTCTCGTTCTTGTGTAGT	74
Il17a	CTCCAGAAGGCCCTCAGACTAC	GGGTCTTCATTGCGGTGG	69
Ifng	TCAGCAACAGCAAGGCGAAA	CCGCTTCCTGAGGCTGGAT	143
Tgfb	GCTGAACCAAGGAGACGGAAT	GAGTTTGTTATCTTTGCTGTCACAAGA	76
Foxp3	CCCAGGAAAGACAGCAACCTT	TTCTCACAACCAGGCCACTTG	89
Tnfa	CATCTTCTCAAAATTCGAGTGACAA	CCTCCACTTGGTGGTTTGCT	63

ISSN: 1479-5876